Skip to main content
Addgene

Park2_L (TAL 3012)
(Plasmid #36004)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 36004 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    JDS 74
  • Vector type
    Mammalian Expression ; T7

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    XL1 Blue
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    TAL array targeting Park2
  • Alt name
    Park2
  • Species
    D. rerio (zebrafish)
  • Entrez Gene
    prkn (a.k.a. p, pa, park2, si:ch211-123f21.1, zgc:112390)
  • Tags / Fusion Proteins
    • 3X Flag (N terminal on backbone)
    • WT FOKI (C terminal on backbone)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site NA (unknown if destroyed)
  • 3′ cloning site NA (unknown if destroyed)
  • 5′ sequencing primer CMV-f
  • 3′ sequencing primer BGH rev
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Addgene's sequencing results identified a single nucleotide mismatch at bp# 3873 when compared to the full plasmid sequence provided by the depositing laboratory. According to the depositing laboratory, this mismatch does not affect the function of the plasmid.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    Park2_L (TAL 3012) was a gift from Keith Joung (Addgene plasmid # 36004 ; http://n2t.net/addgene:36004 ; RRID:Addgene_36004)
  • For your References section:

    Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Sander JD, Cade L, Khayter C, Reyon D, Peterson RT, Joung JK, Yeh JR. Nat Biotechnol. 2011 Aug 5;29(8):697-8. doi: 10.1038/nbt.1934. 10.1038/nbt.1934 PubMed 21822241